Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

21,241 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Outcomes with various drug-eluting or bare metal stents in patients with ST-segment-elevation myocardial infarction: a mixed treatment comparison analysis of trial level data from 34 068 patient-years of follow-up from randomized trials.
Bangalore S, Amoroso N, Fusaro M, Kumar S, Feit F. Bangalore S, et al. Among authors: kumar s. Circ Cardiovasc Interv. 2013 Aug;6(4):378-90. doi: 10.1161/CIRCINTERVENTIONS.113.000415. Epub 2013 Aug 6. Circ Cardiovasc Interv. 2013. PMID: 23922145
Response to letter regarding article, “Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison Analysis of 117,762 patient-years of follow-up from randomized trials”.
Bangalore S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Slater J, Kumar S, Bhatt DL. Bangalore S, et al. Among authors: kumar s. Circulation. 2013 Feb 12;127(6):e447. doi: 10.1161/circulationaha.112.145169. Circulation. 2013. PMID: 23534060 No abstract available.
Carotid artery stenting vs carotid endarterectomy: meta-analysis and diversity-adjusted trial sequential analysis of randomized trials.
Bangalore S, Kumar S, Wetterslev J, Bavry AA, Gluud C, Cutlip DE, Bhatt DL. Bangalore S, et al. Among authors: kumar s. Arch Neurol. 2011 Feb;68(2):172-84. doi: 10.1001/archneurol.2010.262. Epub 2010 Oct 11. Arch Neurol. 2011. PMID: 20937941
Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis.
Bangalore S, Toklu B, Amoroso N, Fusaro M, Kumar S, Hannan EL, Faxon DP, Feit F. Bangalore S, et al. Among authors: kumar s. BMJ. 2013 Nov 8;347:f6625. doi: 10.1136/bmj.f6625. BMJ. 2013. PMID: 24212107 Free PMC article.
Percutaneous coronary intervention versus optimal medical therapy for prevention of spontaneous myocardial infarction in subjects with stable ischemic heart disease.
Bangalore S, Pursnani S, Kumar S, Bagos PG. Bangalore S, et al. Among authors: kumar s. Circulation. 2013 Feb 19;127(7):769-81. doi: 10.1161/CIRCULATIONAHA.112.131961. Epub 2013 Jan 16. Circulation. 2013. PMID: 23325526
When conventional heart failure therapy is not enough: angiotensin receptor blocker, direct renin inhibitor, or aldosterone antagonist?
Bangalore S, Kumar S, Messerli FH. Bangalore S, et al. Among authors: kumar s. Congest Heart Fail. 2013 May-Jun;19(3):107-15. doi: 10.1111/chf.12011. Epub 2012 Dec 12. Congest Heart Fail. 2013. PMID: 23241032 Review.
Blood pressure targets in patients with coronary artery disease: observations from traditional and Bayesian random effects meta-analysis of randomised trials.
Bangalore S, Kumar S, Volodarskiy A, Messerli FH. Bangalore S, et al. Among authors: kumar s. Heart. 2013 May;99(9):601-13. doi: 10.1136/heartjnl-2012-301968. Epub 2012 Aug 21. Heart. 2013. PMID: 22914531 Review.
Outcomes with various drug eluting or bare metal stents in patients with diabetes mellitus: mixed treatment comparison analysis of 22,844 patient years of follow-up from randomised trials.
Bangalore S, Kumar S, Fusaro M, Amoroso N, Kirtane AJ, Byrne RA, Williams DO, Slater J, Cutlip DE, Feit F. Bangalore S, et al. Among authors: kumar s. BMJ. 2012 Aug 10;345:e5170. doi: 10.1136/bmj.e5170. BMJ. 2012. PMID: 22885395 Free PMC article.
Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117 762 patient-years of follow-up from randomized trials.
Bangalore S, Kumar S, Fusaro M, Amoroso N, Attubato MJ, Feit F, Bhatt DL, Slater J. Bangalore S, et al. Among authors: kumar s. Circulation. 2012 Jun 12;125(23):2873-91. doi: 10.1161/CIRCULATIONAHA.112.097014. Epub 2012 May 14. Circulation. 2012. PMID: 22586281
Antihypertensive drugs and risk of cancer: network meta-analyses and trial sequential analyses of 324,168 participants from randomised trials.
Bangalore S, Kumar S, Kjeldsen SE, Makani H, Grossman E, Wetterslev J, Gupta AK, Sever PS, Gluud C, Messerli FH. Bangalore S, et al. Among authors: kumar s. Lancet Oncol. 2011 Jan;12(1):65-82. doi: 10.1016/S1470-2045(10)70260-6. Epub 2010 Nov 29. Lancet Oncol. 2011. PMID: 21123111
21,241 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page
Feedback